Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200
09 juin 2015 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 9, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing...
Elite Pharmaceuticals Announces First Shipment of Generic Isradipine Capsules
15 janv. 2015 10h46 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the first shipments of generic Isradipine 2.5 mg and 5.0 mg...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015
18 nov. 2014 18h24 HE
|
Elite Pharmaceuticals, Inc.
Revenues increase by 8%
Conference Call Scheduled for Wednesday, November 19 at 11:00 AM EST
NORTHVALE, N.J., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the...
Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, November 19, 2014
13 nov. 2014 17h02 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals Announces Bridge Loan Facility
16 oct. 2013 07h45 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 16, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that it has entered into a credit line agreement ("Credit Line") with Nasrat...
Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products
08 oct. 2013 07h45 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 8, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the signing of a Manufacturing and License Agreement ("Agreement")...
Elite Pharmaceuticals Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
03 sept. 2013 09h46 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global...
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2014
14 août 2013 16h29 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral abuse-resistant...
Elite Pharmaceuticals, Inc. Announces Fiscal Year 2014 First Quarter Conference Call on Thursday, August 15, 2013
13 août 2013 11h59 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 13, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
12 août 2013 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 12, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP) today announced the appointment of industry veteran Doug Plassche as Executive Vice President of Operations...